Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft Intervention

American Journal of Cardiology

Volumn 105, Issue 8, 2010, Pages 1076-1082

  Lee, Michael S ^a   Yang, Tae ^a   Kandzari, David E ^b   Tobis, Jonathan M ^a   Liao, Hsini ^c   Mahmud, Ehtisham ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS CLINIC   (United States)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTICLE; BARE METAL STENT; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EMBOLISM PREVENTION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PACLITAXEL; SAPHENOUS VEIN; SIROLIMUS; TREATMENT OUTCOME; UNITED STATES;

EID: 77950370532     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.006     Document Type: Article

References (28)

1. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
3. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnàr F., Falotico R., and RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
4. Assali A., Raz Y., Vaknin-Assa H., Ben-Dor I., Brosh D., Teplitsky I., Fuchs S., and Kornowski R. Beneficial 2-year results of drug-eluting stents in saphenous vein graft lesions. Eur Interv 4 (2008) 108-114
5. van Twisk P.H., Daemen J., Kukreja N., van Domburg R.T., and Serruys P.W. Four-year safety and efficacy of the unrestricted use of sirolimus and paclitaxel-eluting stents in coronary artery bypass grafts. Eur Interv 4 (2008) 311-317
6. Okabe T., Lindsay J., Buch A.N., Steinberg D.H., Roy P., Slottow T.L., Smith K., Torguson R., Xue Z., Satler L.F., Kent K.M., Pichard A.D., Weissman N.J., and Waksman R. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol 102 (2008) 530-534
7. Jeger R.V., Schneiter S., Kaiser C., Bonetti P.O.B.-L.R.H., Handke M., Osswald S., Buser P.T., Pfisterer M.E., and BASKET Investigators. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions. Cardiology 112 (2008) 49-55
8. Kaplan S., Barlis P., Kiris A., Dimopoulos K., Celik S., and Di Mario C. Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions. Acute Card Care 10 (2008) 88-92
9. Gioia G., Benassi A., Mohendra R., Chowdhury K., Masood I., and Matthai W. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Catheter Cardiovasc Interv 72 (2008) 13-20
10. Ramana R.K., Ronan A., Cohoon K., Homan D., Sutherland J., Steen L., Liu J., Loeb H., and Lewis B.E. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. Catheter Cardiovasc Interv 71 (2008) 886-893
11. Vignali L., Saia F., Manari A., Santarelli A., Rubboli A., Varani E., Piovaccari G., Menozzi A., Percoco G., Benassi A., Rusticali G., Marzaroli P., Guastaroba P., Grilli R., Maresta A., and Marzocchi A. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry). Am J Cardiol 101 (2008) 947-952
12. Bansal D., Muppidi R., Singla S., Sukhija R., Zarich S., Mehta J.L., and Sachdeva R. Percutaneous intervention on the saphenous vein bypass grafts-long-term outcomes. Catheter Cardiovasc Interv 71 (2008) 58-61
13. Minutello R.M., Bhagan S., Sharma A., Slotwiner A.J., Feldman D.N., Cuomo L.J., and Wong S.C. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease. J Interv Cardiol 20 (2007) 458-465
14. Ellis S.G., Kandzari D., Kereiakes D.J., Pichard A., Huber K., Resnic F., Yakubov S., Callahan K., Borgman M., and Cohen S.A. Utility of sirolimus-eluting Cypher™ stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study. J Invasive Cardiol 19 (2007) 404-409
15. Vermeersch P., Agostoni P., Verheye S., Van den Heuvel P., Convens C., Van Den Branden F., and Van Langenhove G. DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 50 (2007) 261-267
16. Hoffmann R., Pohl T., Koster R., Blindt R., Boeckstegers P., and Heitzer T. Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. Heart 93 (2007) 331-334
17. Lee M.S., Shah A.P., Aragon J., Jamali A., Dohad S., Kar S., and Makkar R.R. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 66 (2005) 507-511
18. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., Montorfano M., Michev I., Airoldi F., Carlino M., Corvaja N., and Colombo A. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol 45 (2005) 989-994
19. Brilakis E.S., Lichtenwalter C., de Lemos J.A., Roesle M., Obel O., Haagen D., Saeed B., Gadiparthi C., Bissett J.K., Sachdeva R., Voudris V.V., Karyofillis P., Kar B., Rossen J., Fasseas P., Berger P., and Banerjee S. A randomized-controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions. J Am Coll Cardiol 53 (2009) 919-928
20. Lozano I., García-Camarero T., Carrillo P., Baz J.A., de La Torre J.M., López-Palop R., Pinar E., Salvatella N., Avanzas P., and Valdés M. Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results. Rev Esp Cardiol 62 (2009) 39-47
21. Wohrle J., Nusser T., Kestler H.A., Kochs M., and Hombach V. Comparison of the slow-release polymer based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clin Res Cardiol 96 (2007) 70-76
22. Guo J.C., Xu M., Wang G.Z., and Ma C.S. Late lumen loss of drug eluting stents versus bare metal stents for saphenous vein graft intervention. J Clin Rehab Tiss Eng Res 12 (2008) 6971-6975
23. Vermeersch P., Agostoni P., Verheye S., Van den Heuvel P., Convens C., Bruining N., Van Den Branden F., and Van Langenhove G. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial. J Am Coll Cardiol 48 (2006) 2423-2431
24. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C., and BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting vs. bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
25. Ong A.T., McFadden E.P., Regar E., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
26. Wessely R., Kastrati A., and Schömig A. Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. Ann Intern Med 143 (2005) 392-394
27. Keeley E.C., Velez C.A., O'Neill W.W., and Safian R.D. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 38 (2001) 659-665
28. de Jaegere P.P., van Domburg R.T., Feyter P.J., Ruygrok P.N., van der Giessen W.J., van den Brand M.J., and Serruys P.W. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 28 (1996) 89-96